Baltimore: Urban & Fischer, 2003. S. 695-713. Schwartz FW , Bitzer EM (2003). Theorien von Bedarf. Terminologie und Konzepte aus der SIcht des Sachverständigenrates. Praxis Klinische Verhaltensmedizin und [...] :4-6. Bitzer EM, Dörning H, Schwartz FW (2000). Hüftgelenkoperationen in der Routineversorgung – Determinanten der Lebensqualität. Sozial- und Präventivmedizin 2000; 45:125-133. Bitzer EM, Dörning H, Schwartz [...] Gesundheitswissenschaften 7 (3) (1999) 196-209 Busse R, Hoopmann M, Schwartz FW (1999). Which factors determine the use of diagnostic imaging technologies for gastrointestinal complaints in general medical practice
Klusmann JH. J Clin Oncol. 2018 Apr 1;36(10):1007-1016. doi: 10.1200/JCO.2017.75.2204. EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via
Gotina L, Lim S, Jahreis K, Vollbrecht AL, Kim YK, Pae AN, Labus J, Ponimaskin E. Structural determinants for activation of the Tau kinase CDK5 by the serotonin receptor 5-HT7R. Cell Commun Signal. 2024 [...] Mikesh M, Smith I, Nave KA, Schwab MH, Thompson WJ. Neuregulin1 displayed on motor axons regulates terminal Schwann cell-mediated synapse elimination at developing neuromuscular junctions. Proc Natl Acad
Ohkura, R., Shimada, T., Manstein, D.J., and Sutoh, K. (2006). Functional characterization of the N-terminal region of myosin-2. J Biol Chem 281 , 36102-36109. (Abstract)(pdf) Fedorov, R., Witte, G., Urbanke
Pharmacol . Published online August 1, 2025. doi:10.1007/s00210-025-04471-7. Bindel LJ, Seifert R . Determinants of prescribing behaviour of antibacterial drugs in Europe and use of appropriate nomenclature [...] 3390/ijms23042015. Seifert R , Alexander S. Perspective article: A proposal for rational drug class terminology. Br J Pharmacol. 2022; 179(17):4311-4314. doi: 10.1111/bph.15916. Seifert R, Schirmer B . cCMP [...] Viejo-Borbolla A. Generation of hiPSC-derived low threshold mechanoreceptors containing axonal termini resembling bulbous sensory nerve endings and expressing Piezo1 and Piezo2. Stem Cell Res 2021; 56:
Schwerpunkt: Onkologie und OP / Hauttumorzentrum Leitung Hauttumorzentrum Ärztliche Bereichsleitung Dermatoonkologie: Prof.'in Dr. med. Imke von Wasielewski Oberärztin, Stellvertretende Leitung Dermat